eISSN: 2378-3176
Submit manuscript...
Case Report Volume 13 Issue 1
Successful judgment-based steroid management of bevacizumab-induced acute kidney injury with suspected renal-limited thrombotic microangiopathy in a patient with colon cancer: a case report
Abdulrahman Bahatheq, Abdulaziz Mohammed Bajubair, Abdullah Alaa Farid, Rasha A.Alsulami, Zahra Kadhem Abdulnabi, Alaaeldin Helmy Darwish, Ahmed AkL
Received: October 31, 2025 | Published: November 13, 2025
Citation: Bahatheq A, Bajubair AM, Farid AA, et al. Successful judgment-based steroid management of bevacizumab-induced acute kidney injury with suspected renal-limited thrombotic microangiopathy in a patient with colon cancer: a case report. Urol Nephrol Open Access J. 2025;13(1):8-10. DOI: 10.15406/unoaj.2025.13.00362
Abstract
It is challenging to identify the aetiology of acute kidney injury in cancer patients since it can be multifactorial. Renal-limited thrombotic microangiopathy (rTMA) is a rare but recognized complication associated with certain antineoplastic therapies. Diagnosing rTMA in the context of bevacizumab therapy requires a high level of suspicion. In here, we report steroid responsive acute kidney injury associated with induction therapy with bevacizumab therapy.
Keywords: microangiopathy, bevacizumab therapy, kidney, angiogenesis
©2025 Bahatheq, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.